What is Roth Capital’s Forecast for CervoMed Q1 Earnings?
CervoMed Inc. (NASDAQ:CRVO – Free Report) – Roth Capital issued their Q1 2026 EPS estimates for CervoMed in a research note issued on Tuesday, March 18th. Roth Capital analyst B. Pachaiyappan forecasts that the company will post earnings per share of ($0.52) for the quarter. Roth Capital currently has a “Strong-Buy” rating on the stock. […]
CervoMed Inc. (NASDAQ:CRVO – Free Report) – Roth Capital issued their Q1 2026 EPS estimates for CervoMed in a research note issued on Tuesday, March 18th. Roth Capital analyst B. Pachaiyappan forecasts that the company will post earnings per share of ($0.52) for the quarter. Roth Capital currently has a “Strong-Buy” rating on the stock. […]
